CN Patent

CN102898325B — 替加环素晶体及其制备方法

Assigned to Jiangsu Aosaikang Pharmaceutical Co Ltd · Expires 2015-07-08 · 11y expired

What this patent protects

本发明涉及替加环素新的固体结晶形式，并包含了制备这些结晶固体形式的方法。本发明提供的替加环素固体结晶形式具有良好的稳定性和溶解速率。

USPTO Abstract

本发明涉及替加环素新的固体结晶形式，并包含了制备这些结晶固体形式的方法。本发明提供的替加环素固体结晶形式具有良好的稳定性和溶解速率。

Drugs covered by this patent

Patent Metadata

Patent number
CN102898325B
Jurisdiction
CN
Classification
—
Expires
2015-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Aosaikang Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.